April 16, 2026 10:00 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘We are surprised’: SC stays Pawan Khera’s bail over remarks on Himanta Biswa Sarma’s wife | Historic shift: Bihar gets first BJP CM as Samrat Choudhary takes oath | 'ECI deviated from Bihar procedure': Supreme Court raises concerns over voter deletion in Bengal SIR | Noida workers’ protest turns violent: Stones pelted, vehicles damaged over wage hike demand | Oil prices jump above $103 a barrel as US moves to block Iran-linked shipping | I don’t care if they come back or not, says Trump after Iran talks collapse | Legendary singer Asha Bhosle suffers cardiac arrest, hospitalised | Big boost to India–Mauritius ties: S. Jaishankar hands over 90 e-buses | Middle East tension: Iranian delegation arrives in Islamabad for major talks, 10,000 security personnel deployed | Ranveer Singh visits RSS HQ amid Dhurandhar 2 success, triggers speculation
Pfizer
WIKIMEDIA COMMONS

Spain expects to receive 20Mln Pfizer vaccine doses in early 2021: Spanish Health Minister

| @indiablooms | Nov 10, 2020, at 11:52 pm

Moscow/UNI: The Spanish government expects to receive 20 million doses of Pfizer vaccine by early 2021, said Spanish Health Minister Salvador Illa said on Tuesday.

Illa said that his country is planning to sign a contract with Pfizer and some other companies regarding delivery of the COVID-19 vaccine during the coming two weeks.

While speaking to the TVE channel he said that about 10 million people would be vaccinated through these vaccines "We estimate that we will receive about 20 million doses of Pfizer vaccine. It is a double dose vaccine, so about 10 million people can be vaccinated. The vaccines will be free, they will be distributed through the national health system."

The minster stated that the decision on who will receive the vaccine first would be determined by the experts from the health ministry and autonomous communities.

Illa added that there would be no problems with the delivery of the vaccine that must be kept at an ultralow temperature, as the producers guarantee the right temperature.

On Monday, German company BioNTech and its US partner Pfizer announced a successful third phase of clinical trials of the COVID-19 vaccine. It demonstrates over 90 percent efficiency in preventing the coronavirus disease, the companies said.  

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.